Financial News

Financial Report: Sanofi

Pharmaceutical sales down 5% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi   4Q Revenues: €9.3 billion (+2%) 4Q Earnings: €1.7 billion (-7%) FY Revenues: €37.1 billion (+10%) FY Earnings: €7.4 billion (+8%) Comments: Pharmaceutical sales were €7.3 billion in the quarter, down 5% at constant exchange rates (CER). Diabetes sales were €1.9 billion, down 13%, impacted by a decline Lantus sales (-20% to €1.5 billion) mainly reflecting higher discounts. Genzyme sales were €1.0 billion in the quarter, up 28% driven by Aubagio sales, up 70% to €272 million...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters